Neuropace, Inc. (NPCE) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neuropace, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.537 Greetings and welcome to the NeuroPace First Quarter 2025 Earnings Conference Call. 00:00:05.537 -- 00:00:08.680 At this time, all participants are in a listen-only mode. 00:00:08.680 -- 00:00:11.743 A question and answer session will follow the formal presentation. 00:00:11.743 -- 00:00:15.527 If anyone should require operator assistance, please press star zero on your telephone 00:00:15.527 -- 00:00:19.531 keypad. As a reminder, this conference is being recorded. 00:00:19.531 -- 00:00:24.416 It is now my pleasure to introduce Jeremy Pfeffer of LifeSci Advisors. 00:00:24.416 -- 00:00:26.795 Please go ahead. 00:00:26.795 -- 00:00:32.165 Good afternoon. Thank you for joining us for Neuropace's first quarter 2025 financial 00:00:32.165 -- 00:00:36.593 and operating results conference call. On today's call, we will hear from Joel Becker, 00:00:36.593 -- 00:00:40.900 Chief Executive Officer, and Rebecca Kuhn, Chief Financial Officer. 00:00:40.900 -- 00:00:44.908 Earlier today, Neuropace released financial results for the first quarter ended March 00:00:44.908 -- 00:00:47.011 31st, 2025. 00:00:47.011 -- 00:00:51.888 A copy of the press release is available on the company's website at neuropace.com. 00:00:51.888 -- 00:00:55.713 Before we begin, I would like to remind you that throughout this call, we will make statements 00:00:55.713 -- 00:00:59.799 that include forward-looking statements within the meaning of federal securities laws, 00:00:59.799 -- 00:01:03.764 which are made pursuant to the safe harbor provisions of the Private Securities Litigation 00:01:03.764 -- 00:01:06.147 Reform Act of 1995. 00:01:06.147 -- 00:01:10.133 Any statements made during this call that relate to expectations or predictions of future 00:01:10.133 -- 00:0...